FTSE 100 news / Companies and sectors / Pharma and healthcare / 11 October 2026
Pharma and healthcare: sector news on Sunday 11 October 2026
Average tone +7.3 (strongly positive) across 2 companies with relevant coverage, from 5 stories.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| GSK | +7.5 | 3 | Coverage centred on an $800 million GSK investment bringing 300 jobs, which reads well for the company. |
| AstraZeneca | +7.0 | 2 | Coverage was mainly about AstraZeneca's new AI tie-up for its biologics labs and a senior hire in solid tumour cell therapy. |
| Convatec | – | 0 | |
| Haleon | – | 0 | |
| Smith & Nephew | – | 0 |
Strongest stories in the sector
- +10.0 Shapiro secures $800 million GSK investment, 300 jobs
$800 million GSK investment and 300 jobs secured in Pennsylvania. - +8.5 AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie Up
New AI discovery partnership for biologics labs is a positive development. - +5.8 Alteogen ALT-B4-based ‘Jemperli SC’ heads into clinical trials, GSK signals November start
GSK signals November start for Jemperli subcutaneous clinical trials. - +3.7 Levi Gray-Rupp Joins AstraZeneca as Global Product Lead, Solid Tumor Cell Therapy
Senior hire in cell therapy supports oncology build-out. - +0.5 GSK stock is unchanged at EUR 20.75 with a weekly high of EUR 20.84
Share price flat at EUR 20.75, purely factual.
Pharma and healthcare: every day · FTSE 100 overview for the day